Clinical Trials Directory

Trials / Unknown

UnknownNCT04899960

Drug-Related Problems in Neonatal Patients

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
512 (estimated)
Sponsor
Hacettepe University · Academic / Other
Sex
All
Age
1 Hour – 28 Days
Healthy volunteers
Not accepted

Summary

Drug-related problems in newborn babies have been reported with a rate of 4-30%. It is estimated that the higher rates of these problems in hospitalized children under the age of two are related to the variety of drugs used and the differences in the age, weight and diagnosis of the patients. In this context, with the clinical parameters and demographic data obtained in the first 24 hours of the patients hospitalized in the neonatal intensive care unit, machine learning algorithms are used to predict the risks that may arise from possible drug-related problems (prescribing and administration errors, side effects and drug-drug interactions) that may occur during hospitalization. The algorithm, which will be created by modeling with a high number of big data pool, is planned to be transformed into a clinical decision support system software that can be used easily in clinical practice with online and mobile applications. By processing the data of the patients to be included in the model, it is aimed to prevent and manage drug-related problems before they occur, as well as to provide cost-effective medşcation treatment to patients hospitalized in the neonatal intensive care unit, together with a reduction in the risk of drug-related mortality and morbidity.

Conditions

Interventions

TypeNameDescription
DRUGClinical Pharmacist InterventionPrevention of drug-related problems by clinical pharmacist in neonatal intensive care unit.

Timeline

Start date
2020-02-01
Primary completion
2021-11-01
Completion
2021-11-01
First posted
2021-05-25
Last updated
2021-09-02

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT04899960. Inclusion in this directory is not an endorsement.